Skip to content
Open Data Finder
Open Government Canada

Guidance Document: Information and Submission Requirements for Biosimilar Biologic Drugs

Published by Health Canada | Santé Canada

About this dataset

This guidance document applies to all biologic drug submissions where the sponsor seeks authorization for sale based on demonstrated similarity to a previously approved biologic drug and relies, in part, on prior information regarding that biologic drug in order to present a reduced clinical and non-clinical package as part of the submission.

Guidance Document: Information and Submission Requirements for Biosimilar Biologic Drugs · Open Data Finder